TNF inhibitors for the management of inflammatory heart disease in spondyloarthritis: French multicentre case-series and literature review

Rheumatology (Oxford). 2021 Jul 1;60(7):e247-e249. doi: 10.1093/rheumatology/keab082.

Authors

Juliette Tennenbaum¹, Noémie Abisror¹, Jérémie Sellam², Adrien Bigot³, Clément Gourguechon⁴, Amir Adedjouma¹, Azeddine Dellal⁵, Olivier Fain¹, Arsène Mekinian¹; Club Rhumatismes et Inflammations (CRI)

Affiliations

¹ Internal Medicine Department.
² Rheumatology Department, Inflammation-Immunopathology-Biotherapy Department (DMU 3iD), Sorbonne University AP-HP, Hôpital Saint Antoine, Paris.
³ Internal Medicine Department, Centre Hospitalier Universitaire, Tours.
⁴ Internal Medicine Department, Hôpital d'Abbeville, Abbeville, Normandie.
⁵ Internal Medicine and Rheumatology Department, Hôpital de Montfermeil, Montfermeil, Île-de-France, France.

PMID: 33502470
DOI: 10.1093/rheumatology/keab082

No abstract available

Publication types

Review

MeSH terms

Adult
Arthritis, Psoriatic / complications
Arthritis, Psoriatic / drug therapy*
Chronic Disease
Female
France
Humans
Male
Myocarditis / complications
Myocarditis / drug therapy*
Pericarditis / complications
Pericarditis / drug therapy*
Recurrence
Spondylitis, Ankylosing / complications
Spondylitis, Ankylosing / drug therapy*
Tumor Necrosis Factor Inhibitors / therapeutic use*
Young Adult

Substances

Tumor Necrosis Factor Inhibitors